For many, successful management of diabetes requires constant and diligent monitoring, multiple daily injections and/or the coordination of multiple oral medicines alongside a patient’s carefully planned daily routine to avoid serious disease complications. As a result, treatments offering better or more sustained glycemic control, reduced pill burden, more convenient delivery mechanisms, less frequent injections or simplified daily routines are remarkably valuable to patients with diabetes. The treatment advances occurring over the past decade have each sought to meet these important needs and improve and extend the lives of the millions of Americans struggling to manage this deadly and burdensome chronic condition.
However, as prevalence of the disease is expected to more than double over the coming decades, the importance of expanding treatment options that contribute to better management and control will continue to grow from both a patient and societal perspective. The continued development of medicines that meet the diverse needs of patients with diabetes, facilitate the ability for patients to remain adherent to treatment and achieve adequate glycemic control will prove critical to avoid the serious and expensive complications of the disease into the future.Building on the progress made in the treatment of diabetes over the past decade, researchers continue to strive to bring important new treatment options to patients with both type1 and type 2 diabetes—including insulins that may provide even longer duration of action for patients. Today, more than 200 medicines are in development to treat diabetes and diabetes related conditions, such as chronic kidney failure and diabetic neuropathy. These potential medicines offer hope to the millions of patients who face challenges in successfully managing this complex chronic disease as well as its related complications.